Study of a heart pump for high-risk angioplasty
Part of Heart & circulation clinical trials.
This trial tests a temporary heart pump (called the KARDION Cory P4) used during a high-risk angioplasty (stenting) procedure. The pump helps keep blood flowing in patients whose heart is weak or who have complex blockages, aiming to make the procedure safer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 90 years old
- Your heart's pumping strength (LV ejection fraction) is less than 50%
- You have complex blockages in your heart arteries, such as a blocked left main artery or severe three-vessel disease
- A heart team (cardiologist and surgeon) has said you are a good candidate for angioplasty with a heart pump
- The blood vessel in your leg (used for the pump) is bigger than 5.5 mm
- You are willing to follow the study schedule and sign a consent form
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new heart pump (Ventiflow LP) that helps support the heart during a procedure to open blocked coronary arteries (angioplasty or PCI) in people whose hearts are weak. It may help those who are too high risk for bypass surgery.
This study tests whether using a special heart pump (called Impella) during a high-risk procedure to open blocked heart arteries can help protect your heart. It aims to see if this support improves the success and safety of the procedure in people with weak hearts.
This study tests a new device (the VentriCure) that temporarily helps your heart pump during a stent procedure. It is for people with heart failure and blocked arteries who are at high risk for bypass surgery.
This study looks at treatment options for adults with significantly reduced heart pumping strength and extensive coronary artery disease. It may help people who are at higher risk due to widespread blocked heart arteries, but eligibility depends on recent heart events and bleeding risk.
This trial tests the iVAC 2L device, a temporary heart pump placed in the main artery, to help patients who need a high-risk angioplasty (PCI) because of a very narrowed or blocked coronary artery. The goal is to prevent the heart from failing during the procedure.
This study tests a temporary heart pump called Phimume® that is inserted through a blood vessel in the leg to help your heart pump blood during a high-risk heart procedure. It is for people with very weak hearts who cannot safely have standard heart surgery.
Hear when a new Coronary artery disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.